
Retatrutide: Triple Receptor Agonism and the Biology Behind GIP, GLP-1 and Glucagon Co-Activation
Retatrutide combines GIP, GLP-1 and glucagon receptor activity in a single investigational therapy. This review examines its mechanism, clinical evidence and unanswered questions.
· Peptimize Editorial





